Kalaris Therapeutics Statistics
NASDAQ: KLRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.28-0.07 (-5.19%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Kalaris Therapeutics by the numbers
Kalaris Therapeutics has a market capitalization of $30.5 million based on 23.80M shares outstanding. With trailing EPS of $-1.84, Kalaris Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.0% below its 50-day average and 73.6% below its 200-day average.
Average daily trading volume is 77.37K shares, or about $99,035 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KLRS valuation vs. peer median
| Metric | KLRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $30.47M | $26.01M | +17% |
| Avg. volume | 77.37K | 124.11K | -38% |
Peer median across 8 companies: CRBU, EXOZ, LONA, INMB, TIL, PTHS, SAEN, MGX.
Valuation
- Market cap
- $30.47M
- EPS (TTM)
- $-1.84
- Shares outstanding
- 23.80M
Price and trading
- Previous close
- 1.35
- Open
- 1.31
- Day range
- 1.25 – 1.37
- 52-week range
- 1.25 – 11.88
- 52-week change
- -81.74%
- Beta
- —
- Volume
- 37.99K
- Average volume
- 77.37K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 30.47M
- Forward Pe
- -0.75
- Eps
- -1.84
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.88
- Week52 Low
- 1.25
- Avg Volume
- 77,371.00
- Shares Outstanding
- 23.80M
- Ma50
- 2.33
- Ma200
- 4.84
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -89.23%
- Pct From52w Low
- 2.40%